ELOVL1-IN-3
ELOVL1-IN-3 (Compound 22) is a potent and orally active inhibitor of elongation of very long chain fatty acid 1 (ELOVL1) enzyme. ELOVL1-IN-3 serves as a useful tool for researching adrenoleukodystrophy (ALD) [1].
Product Specifications
CAS Number
2761063-99-2
UNSPSC
12352005
Target
ELOVL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/elovl1-in-3.html
Purity
99.81
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
[C@@H]1(C2=CC=CC=C2)OCCN(C3=CC(O[C@@H]4C[C@H](N5C=CC=N5)C4)=NC=N3)C1
Molecular Formula
C21H23N5O2
Molecular Weight
377.44
References & Citations
[1]Boyd MJ, et al. Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1. J Med Chem. 2021;64 (24) :17777-17794.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY428764 100 µg
IKK gamma (IKBKG) (NM_001145255) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC941718-500 1x 500 µL
Bcl-6 (Follicular Lymphoma Marker) (BCL6/1718), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details